TREA

97402108 - YOCHANRA

Follow

Information

  • Trademark
  • 97402108
  • Serial Number
    97402108
  • Registration Number
    7394944
  • Filing Date
    May 09, 2022
    3 years ago
  • Registration Date
    May 28, 2024
    11 months ago
  • Transaction Date
    May 28, 2024
    11 months ago
  • Status Date
    May 28, 2024
    11 months ago
  • Published for Opposition Date
    March 12, 2024
    a year ago
  • Location Date
    May 27, 2024
    11 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MAYES, LAURIE ANN
  • Attorney Docket Number
    0579-0880US1
    Attorney Name
    Michael T. Smith
  • Owners
Information
Mark Drawing Code
4
Mark Identification
YOCHANRA
Case File Statements
  • GS0051: Medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; drugs for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemico-pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biological preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; bulk medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biochemical medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for pharmaceutical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines in the nature of tablets for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders in the nature of capsule; injectable medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders
Case File Event Statements
  • 5/12/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/16/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/25/2023 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/3/2023 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/3/2023 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/14/2023 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/14/2023 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/15/2023 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/17/2023 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/3/2023 - 2 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/23/2023 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/23/2023 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/18/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/12/2023 - a year ago
    15 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR
  • 9/12/2023 - a year ago
    16 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG
  • 11/9/2023 - a year ago
    17 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/9/2023 - a year ago
    18 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/9/2023 - a year ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/9/2023 - a year ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/9/2023 - a year ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/10/2024 - a year ago
    22 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 1/18/2024 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2024 - a year ago
    24 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/18/2024 - a year ago
    25 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/20/2024 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/6/2024 - a year ago
    27 - ASSIGNED TO PETITION STAFF Type: APET
  • 2/7/2024 - a year ago
    28 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 2/7/2024 - a year ago
    29 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 2/8/2024 - a year ago
    30 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 2/8/2024 - a year ago
    31 - CASE RETURNED TO EXAMINATION Type: OTHE
  • 2/21/2024 - a year ago
    32 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/21/2024 - a year ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/12/2024 - a year ago
    34 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/12/2024 - a year ago
    35 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/28/2024 - 11 months ago
    36 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/28/2024 - 11 months ago
    37 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC